Test Price
2,800 AED✅ Home Collection Available
UMOD Gene Medullary Cystic Kidney Disease Type 2 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
This precise genetic test provides confirmatory diagnosis of UMOD gene mutations causing Medullary Cystic Kidney Disease Type 2, backed by ISO 9001:2015 quality assurance and DHA licensing.
Test Overview & Methodology
The UMOD gene test employs Next Generation Sequencing (NGS) to comprehensively analyze the gene associated with autosomal dominant tubulointerstitial kidney disease. This enables early nephrology intervention and familial risk stratification. The test provides full gene coverage, including exonic, intronic, and regulatory regions, ensuring detection of all clinically relevant variants.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Technology | NGS – Full gene sequencing | Targeted exon sequencing |
| Detection Rate | >99% for all UMOD variants | ~90% (misses deep intronic & large rearrangements) |
| Turnaround Time | 3–4 Weeks | 5–6 Weeks |
Pre-Test Requirements
A genetic counselling session to draw a pedigree chart of affected family members is mandatory. Clinical history relevant to UMOD-related kidney disease must be provided. The test requires a blood sample (whole blood, extracted DNA, or one drop blood on FTA card). No fasting or special preparation needed.
Physician Insight & Safety Protocols
“This genetic test is a critical tool for identifying UMOD mutations that drive Medullary Cystic Kidney Disease Type 2. As a DHA-licensed clinical geneticist, I strongly advise that results be interpreted alongside renal imaging and family history. Always consult with a nephrologist before making any treatment decisions.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.
Advisory: Medication Safety
Do not discontinue prescribed medication based on test results without consulting your doctor. The genetic test does not replace ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- Inability to provide informed consent (as per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Acute febrile illness or recent blood transfusion within 3 weeks (may compromise DNA integrity).
- Severe anaemia (Hb < 7 g/dL) – discuss with ordering physician.
- ER Red Flags: Sudden flank pain, anuria, severe hypertension – seek immediate medical care.
Patient FAQ & Clinical Guidance
1. What is the UMOD gene test for Medullary Cystic Kidney Disease Type 2?
Snippet Answer: This DNA test sequences the entire UMOD gene using Next Generation Sequencing to detect mutations causing autosomal dominant tubulointerstitial kidney disease, enabling early diagnosis and family risk assessment.
The test is recommended for individuals with a family history of unexplained chronic kidney disease, early‑onset gout, or medullary cysts on renal ultrasound.
2. How is the sample collected and what is the turnaround time?
Snippet Answer: A simple blood draw or buccal swab is collected at home by a DHA-licensed phlebotomist through our VIP Mobile Phlebotomy service, then processed via NGS with results available in 3–4 weeks.
3. Is this covered by UAE health insurance and what is the cost?
Snippet Answer: Priced at 2800 AED. We offer direct insurance billing verification via WhatsApp at +971 54 548 8731; most UAE insurers cover genetic testing when medically necessary.
UAE Regulatory & Data Privacy Adherence
Data Privacy Compliance: This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | UMOD Gene Medullary Cystic Kidney Disease Type 2 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or FTA card |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | Q61.5 |
| LOINC Code | 92907-8 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians